As evidence of tirzepatide’s efficacy mounts across a range of cardiometabolic conditions, Eli Lilly has shown that taking the incretin medicine alongside another of its drugs, Taltz, could lead to ...

A new presidential initiative called QMIT will advance the development of quantum technologies—and help ensure that they are used for good. As MIT navigates a difficult and constantly changing higher ...

(RNS) — From the beginning of his campaign, Zohran Mamdani’s run for mayor of New York has been about overcoming our doubts about what is possible. So it was that on the eve of his inauguration, I sat ...

Only five Sears stores remain in the country, with the end likely near for what was once the mightiest American retailer. square feet Only five Sears stores remain in the country, with the end likely ...

© Ricardo Moreira/Getty ImagesNeymar Junior of Santos talks with their fans before the Brasileirao 2025 match. Neymar Jr. has not yet managed to regain his best form ...

Anthony Joshua has made it clear that he plans to show Jake Paul no mercy Friday in their polarizing Netflix boxing match. Two days out from the bout, Joshua doubled down on that promise. With the ...

Imagine this: your AI agent just approved a $50,000 cloud spend after being told to “optimize infrastructure costs.” Another agent leaked customer data while trying to “organize files for reporting.” ...

Southwest Florida's tourism industry is facing uncertainty, but it's feeling optimistic about 2026. Despite more rooms, demand has softened due to economic factors and a drop in international visitors ...

(FOX40.COM) — Governor Gavin Newsom announced on Monday his commitment to housing equity and affordability by awarding the state $181.1 million in funding to focus on helping thousands of low-income ...

Safety and efficacy data from a phase 1 multicenter study evaluating rapcabtagene autoleucel, an investigational next-generation CD19-directed CAR-T cell therapy that is manufactured in 48 hours using ...

Erika Hamilton, MD, reports early trial data showing DB-1305/BNT325, a TROP2-targeted ADC, produced encouraging responses in heavily pretreated TNBC patients. DB-1305/BNT325, a TROP2-targeted antibody ...

New data from a phase IIb trial extension study suggested that investigational neflamapimod led to significant improvements on key outcomes in people with dementia with Lewy bodies (DLB). In the ...